Jordi Bruix
@bruixj
Followers
2,016
Following
340
Media
189
Statuses
1,402
Catalan hepatologist devoted to liver cancer as a profession and happy to be actively working at the BCLC. Hospital Clinic. IDIBAPS.
Vila de Gracia, Barcelona
Joined December 2015
Don't wanna be here?
Send us removal request.
Explore trending content on Musk Viewer
#BeFairUEFA
• 408453 Tweets
España
• 277675 Tweets
Osama
• 263078 Tweets
#MyLoveMixUpTHep5
• 195003 Tweets
Merih Demiral
• 178835 Tweets
Stray Kids
• 147648 Tweets
Spain
• 106993 Tweets
#原神予告番組
• 103374 Tweets
Orban
• 86914 Tweets
FAYEYOKO LIVE TAOBAO
• 84842 Tweets
LOVE AND EFFORT
• 81793 Tweets
ニィロウ
• 72324 Tweets
#それスノ
• 68396 Tweets
Alemania
• 55661 Tweets
#ビリスク
• 46939 Tweets
Servet
• 34324 Tweets
Natlan
• 31290 Tweets
ナヴィア
• 25274 Tweets
マダックス
• 19456 Tweets
エミリエ
• 19177 Tweets
Nilou
• 16183 Tweets
Kirara
• 13505 Tweets
キングダム
• 13372 Tweets
復活当選
• 10949 Tweets
Last Seen Profiles
As I transition to an Emeritus status, I am surprised with nice emotional moments prepared by those I have spend years working at
@hospitalclinic
. They even set up a placque to honor me at the outpatient clinic. Overflow of happiness and sincere appreciation
@idibaps
13
6
196
Proud and happy to receive the
@ILCAnews
award that I take as an award to the
@BCLC_group
as well as to colleagues, friends and fellows with who I shared my career
@hospitalclinic
@idibaps
@CIBERehd
“With over 630 publications and 43,939 citations, Jordi has changed liver cancer diagnosis, prognostic evaluation and treatment.” -
@Zucmanrossi
Congratulations to ILCA’s Founder
@bruixj
on the Nelson Fausto Award! ✨
#ILCA22
#LiverTwitter
@BCLC_group
1
11
58
27
22
170
My friend Julià Panes retired today after a great career in IBD. We are all getting old and our network of colleagues vanishes step by step. Future can not be avoided!!
@hospitalclinic
@idibaps
@aegastro
@gasclinicbcn
3
18
150
Pity that this is written in Spanish. Great piece about leadership renewal in any organization
@hospitalclinic
@idibaps
@CIBERehd
6
47
142
As a mentee from Prof Bosch
@jaumebosch9
(and now a friend) it is great that he is recovered from illness and acting as
#ILC2020
Hon President. 👏👏👏👏 His creative brain and critical capacity had a major impact in my career after my PhD with him.
@EASLnews
@hospitalclinic
4
10
116
Today is my birthday anniversary. Got a brilliant gift from the
@BCLC_group
Have been a
@FCBarcelona_cat
supporter since childhood and will not change.
@imessi
leading the team signatures!! Will frame it!!
22
5
115
FDA just approved the combo Atezo-Beva for HCC. Big step forward!! All the field will have to be redesigned . Approval by EMA will come and then, reimbursement may take place. Liver cancer units such as BCLC needed
@hospitalclinic
@idibaps
@aeeh
@ILCAnews
@EASLnews
@AASLDtweets
1
31
95
No way to avoid an intense emotion while surrounded by family, friends and colleagues. The human success is what matters, while manuscripts, Impact factor, H-index and alike are fine, but do not become longlasting memories
@hospitalclinic
@idibaps
11
4
88
Today we enjoyed a short visit by Dr Kim, Director of the Liver Cancer Center at Seoul National University Hospital. Proud for the international BCLC recognition and willingness to understand our organization
@ma5RN
&
@JordiRimola
as hosts.
@APASLnews
@hospitalclinic
@idibaps
0
6
77
As predicted!! Emotions took place. Retirement event for
@miquel_navasa
has exposed his virtues a physician, investigator, educator, mentor, friend and more!! He will be missed at
@hospitalclinic
2
7
76
Free access to the
@EASLnews
@EASLedu
position paper about Systemic therapy for HCC. Just for 50 days!!! Proud of the piece
@hospitalclinic
@idibaps
@CIBERehd
@EuropeLiver
@EASL_ilf
@GlobalLiver
@AEEHLiver
0
28
67
Happy to learn that Greg Gores from
@MayoClinic
in Rochester has been appointed as new Editor in Chief for
@HEP_Journal
@AASLDtweets
Friends (me among them) are happy and the field will move further forward.
7
4
64
This is a very comprehensive piece with a great figure as designed at
@JHepatology
. Very timely just after
@ASCO
GI and prior to
@EASLnews
#livercancersummit
Hope to see its impact there
Final proof of BCLC 2022 with nice fig is available at .
Shared effort always pays off!!
@hospitalclinic
@idibaps
@CIBERehd
@EASLnews
@AASLDtweets
@ILCAnews
@ASCO
@myESMO
@AEEHLiver
@_SEOM
@EuropeLiver
@SERAM_RX
@SERVEISoc
@aecirujanos
@SETHepatico
5
166
356
1
23
67
Mercé Vidal
@MerceVidalFlor
obtained her PhD about Nursing Care in Diabetes. What a brilliant team with Marga Jansà
@MargaJansa
. Have made major contributions for care/research in diabetes. Congrats to both. See you going up stair 11 at
@hospitalclinic
on Monday!!
@idibaps
3
13
66
Proud to be again among the highly cited authors. Nothing is achieved alone, but rather because of teamwork. Not acknowledging would be dishonest. Note that our work has been clinical research providing evidence for patients care and not bench. The key is doing valuable research.
🎉 Set investigadors del
#CL
ÍNIC-
@idibaps
entre els més rellevants del món segons el ranking
@Clarivate
.
🏥 L'hospital es converteix en la institució mèdica d’Espanya amb el major nombre d'investigadors entre els més citats.
➕ info ▶️
7
97
231
5
6
66
Decide to take a break.
#ILC2021
is to intense without some proper relax! No effective work/learning if tired!
@EASLnews
@EASLedu
@BCLC_group
0
5
60
It is a strange feeling to see Miquel Navasa retiring. We first met as students and have run our career together. Both have had kids and raised them sharing time, stress and concerns. Luckily, friendship lasts beyond work!!
Acto de despedida del Dr. Miquel Navasa el 1 octubre 2021, a las 12-14h en la Aula Magna
@CampusClinicUB
Para poder atender online:👇👇
¡Estáis todos invitados!
14
53
177
0
10
60
End of 2020 around the corner. No way to have cleared the list of pending manuscripts and tasks. Every year the same failure but this time we may blame COVID!! Procastination unknown to us. Thus, we will not fail in 2021!! 😂😂😂
@hospitalclinic
@ciberhed
@idibaps
@livertwitter
1
3
59
Combination of Atezolizumab+Bevacizumab approved by EMA. Now waiting for the reimbursement approval in each country. HCC patients deserve access to effective options that improve survival
@EuropeLiver
@EASLnews
@ILCAnews
@AEEHLiver
@myESMO
@asscatinforma
1
18
55
Just had the first two of the day!! great review.
N Engl J Med 2020; 383:369-378
DOI: 10.1056/NEJMra1816604
3
6
51
The task as AE in
@HEP_Journal
is intense, but easy if surrounded by a team of experts and friends in the Board!! Clinical and lab research are now very hot topics as reflected by the increasing number of very appealing submissions.
@AASLDtweets
1
7
54
I was in the jury for his PhD and stressed him at an AASLD talk with my questions
@sapisochin
. Now opening the field of
#trasplantoncology
and ready to debate with giants in the field
@EASLnews
#LiverCancerSummit
1
4
48
Has been a great event with several moving moments. I am so happy and proud to see the
@BCLC_group
evolving to further success under your leadership!! Meritocracy at its best!!
Today we pay tribute to
@bruixj
a true pioneer in
#livercancer
research. His dedication and passion are a source of inspiration. Proud to lead
@BCLC_group
and continue his legacy with gratitude. 🌟
#TributeToJordiBruix
#LiverCancerResearch
@hospitalclinic
@CIBERehd
@idibaps
10
31
187
0
7
55
Sorry for a delayed congrat to
@Zucmanrossi
for her election as
@ILCAnews
President. 1st woman for such position. A pleasure to have seen her grow since the early days in Bordeaux!!
@WomenScience
@EASLnews
@AASLDtweets
@Inserm
3
9
51
Proud to be again among the Clarivate Highly Cited Authors. This is the success of the
@BCLC_group
members rather than of a single person. Another celebration is due!!
@hospitalclinic
@CIBERehd
Vuit investigadors del Clínic-IDIBAPS i la Universitat de Barcelona al rànquing dels millors del món de 2022
👉
2
7
43
4
1
50
Crec que avui tindré un acte de reconeixement memorable!!! Quina entrada!! És evident que el
@BCLC_group
té nivell científic i humà
@hospitalclinic
@idibaps
1
4
50
This is the official one and will be updated in 2021!!
Management of hepatocellular carcinoma (HCC) according to BCLC staging
@TheLancet
#LiverTwitter
#MedEd
💡
0
30
101
2
11
48
Here the link to free access of the manuscript. Thanks for giving visibility to a big effort
@BCLC_group
🌟Barcelona Clinic Liver Cancer Classification📝 ⏰BCLC 2022 Update
News:
🌀Extension of transplant cr outside Milan
🌀Downstaging🤏
🌀Laparoscopy for HCC resection🔪
🌀Atezo/Beva💊➡️1st line treatment in adv HCC
#GITwitter
#livertwitter
#MedEd
#Medtwitter
@my_ueg
@UEGJournal
3
113
225
1
18
47
Getting ready for the
#livercancer
Summit by
@EASLnews
together with
@NaultJc
@nicole_rich8
@mcolombo46
and
@HepatoEpi
. Will be digital, but not prevent an active debate around hot topics and current state of the art knowledge.
@AASLDtweets
@ILCAnews
@AEEHLiver
1
6
45
One of the most rewarding thing for a mentor is to see mentees progressing and turn into mature physicians and investigators. Proud of all those emerging from the
@BCLC_group
and displaying honesty, innovation and ultimately, peers recognition
@hospitalclinic
@idibaps
Maria Reig
@ma5RN
and Phil Newsome chairing general session 1 at
#ILC2020
@EASLnews
@hospitalclinic
@idibaps
It is all about leadership!!
0
4
35
0
3
44
Positive data in adjuvancy!!! Eager to see the results in detail: target population, magnitude of benefit,…
@BCLC_group
@EASLnews
@AASLDtweets
@AEEHLiver
3
14
46
I have run my hobby with a salary from
@hospitalclinic
&
@UniBarcelona
for decades. Now I exert the hobby with even more joy as it is fully done for pleasure
@idibaps
@CIBERehd
I have a privileged life!!
@BCLC_group
2023 Update celebrating
@bruixj
‘s highly successful hobby of fighting liver cancer 💪
0
4
26
2
2
44
Amazing to see that 20 yrs have passed since the seminal HCC EASL conference that we first run in Barcelona. It was the turning point for the exponential progress in our knowledge of liver cancer. The Summit will prime further growth
@ILCAnews
@AASLDtweets
@AEEHLiver
@EuropeLiver
Digital
#LiverCancerSummit
2021 is less than 2 weeks away! The organising committee & 60+ faculty members are waiting to exchange with you the latest knowledge on
#livercancer
. Register now to join the discussions!
@chiarabraconi
@bruixj
@NaultJc
1
6
15
0
10
44
Happy to have designed this potentially practice changing trial with P.Galle and several new and old friends. Novel end-points aiming to become OS surrogates
@AEEHLiver
@EASLnews
@ILCAnews
@AASLDtweets
0
14
39
Proud to have our
@BCLC_group
study about LT for
#hcc
at
@hospitalclinic
in the front page of
@JHepatology
📢Our November issue is out‼️
Read about:
✅acceptable post
#livertransplant
survival beyond Milan criteria
✅the immunomodulatory effects of
#norUDCA
on T cells
✅maternal obesity & the increased risk & severity of
#NAFLD
in offspring
And much more at👉
0
11
39
0
4
43
HCC immune characterization is getting complex!! Each nodule may have diiferent cell composition. Heterogeneity may explain heterogeneous intrapatient response on a per nodule basis.
Cell. 2020 Sep 24:S0092-8674(20)31082-5. doi: 10.1016/j.cell.2020.08.040. Online ahead of print.
0
7
41
Moltes gràcies. Ha estat memorable i és un reconeixement a tot el grup on els diferents perfils de coneixement treballen conjuntament de manera generosa i honesta. Ara tot segueix sota la coordinació de la Dra
@ma5RN
i jo faré el mentoring que es demani
Gran éxito del acto de reconocimiento a la trayectoria del Dr. Jordi Bruix “Tributo a Jordi Bruix: Jordi más allá de la ciencia” Aula Magna de la Facultad de Medicina (UB).
@bruixj
@BCLC_group
@ma5RN
@rabataller
@Alexfornergon
@hospitalclinic
@idibaps
@UniBarcelona
0
1
18
1
3
41
Just announced. Himalaya testing the combo Treme-Durva opened positive. 1st line for
#HCC
gets further options and complexity
@AEEHLiver
@EASLnews
@AASLDtweets
@ILCAnews
@EuropeLiver
@myESMO
1
23
41
I am really proud to have primed the evolution and transition of the
@BCLC_group
into the future. Getting fellows to become IPs that flourish and lead the generation renewal is the best reward for a mentor.
@hospitalclinic
@idibaps
@CIBERehd
@EASLedu
@AASLDtweets
And now
@ma5RN
talking about trial design for future developments to benefit
#livercancer
patients. Innovation and insight in place !!
@hospitalclinic
@idibaps
@EuropeLiver
@GlobalLiver
0
4
16
0
2
39
We all have experienced lack of concentration during confinement. Also missed the informal exchange of ideas with coworkers and felt it prevented creativity. Psychology studies confirm it. Telecons do not replace face-to-face interaction!
0
4
36
Looking forward to attend the positive Himalaya trial talk by
@GABOUALFA
. 1st line Tx for
#hcc
has evolved to a higher level involving IOs. Already inserted in the 2022
@BCLC_group
model.
@ASCO
@EASLnews
@AASLDtweets
@AEEHLiver
@EuropeLiver
@asscatinforma
1
7
39
Happy to share the link to free access to my opinion piece in
@JHepatology
. Final version on line and hope to trigger critical thinking around trial design and analysis of end-points in
#livercancer
@EASLnews
0
9
35
Review about locoregional therapy for
@HCC
written with R Kloeckner & PR Galle available inpress. Was fun to prepare it when trials around TACE testing different approaches are flourishing. Fig 3 about margin value is nice.
DOI 10.1002/hep.31424
@hospitalclinic
@idibaps
@ciberhed
1
8
37
Advocacy paper about liver cancer coordinated by
@allaire_manon
and M Sherman under
@ILCAnews
Initiative. Worth to get patients voice.
@EASLnews
@AASLDtweets
@AEEHLiver
@alehlatam
@EuropeLiver
@GlobalLiver
@dice_europe
@hospitalclinic
0
20
36
Sad news. I feared of him as a predoc fellow because of his always key questions. Learned from him and respected him a lot to finally relate in a friendly manner. A big honor to have met him along several years. Rest in peace.
@EASLnews
The passing of a giant. Roger Williams, The Father of Transplant Hepatology and a founding Father of Hepatology. Fondly Missed.
@RajivJalan1
@KingsCollegeNHS
@tomhemmingk
@EASLnews
@basl_events
@AASLDtweets
@AASLDPresident
1
17
92
0
3
35
BeiGene Announces Positive Global Phase 3 Trial Results for PD-1 Inhibitor Tislelizumab in First-Line Unresectable Hepatocellular Cancer | Business Wire
3
14
36
Mentoring is always a two ways path. And it is a pleasure to see mentees growing and being successful. Now thinking about several persons I may have influenced even beyond liver cancer
@ILCAnews
@hospitalclinic
@idibaps
@bruixj
@BCLC_group
getting the Nelson award
@ILCAnews
for an unbelievable career - >44000 citations! Thanks for all your amazing mentoring. Incredible and unique human being
#HCC
#CCA
0
5
32
2
3
34
Some people is not aware that
@ma5RN
is the head of the
@BCLC_group
& the Hepatic Oncology Unit at
@hospitalclinic
and
@CIBERehd
since more than 3 years ago. Leadership renewal has been smooth and effective. Happy and proud for it.
@ma5RN
gets the
@AEEHLiver
award to intensify her research in liver cancer. Freeing time to further expand the studies at our group under her leadership
@hospitalclinic
@idibaps
@CIBERehd
6
2
34
1
4
33
We all have negative studies and publish them. Beware of those who always publish positive studies or sell a positive message out of a failed one!!
@serperm
@DrLoomba
@ebtapper
@AmJGastro
has a “Negative” issue but well done negative trials are welcome anytime!
@BrennanSpiegel
@AmCollegeGastro
0
2
17
2
4
34
Yo he resistido!! Ha sido muy emotivo verme rodeado de tanta gente que expresaba aprecio y cariño. Sabía que estabas conectada!!!
Super emotivo tributo a
@bruixj
esta mañana en
@hospitalclinic
con todos los amigos y familiares
@BCLC_group
Desde la distancia, un abrazo enorme.
“La cebolla ha hecho efecto también aquí , querida
@neusllarch
“
🥰🥰🥰🥰
2
2
30
3
5
33
Final telecon 24 hrs prior to the
#livercancersummit
by
@EASLnews
with
@ma5RN
and
@FaubertPochelon
overviewing it all. Already envisioning the Summit for 2022!!
#livercancer
deserves major research.
@NaultJc
@chiarabraconi
and myself are almost the past.
1
1
33
Amazed by the success. Years of work in
#livercancer
within the
@BCLC_group
is the clue for the clinical research work that passes the proof of time!! Shared recognition with all the team
@hospitalclinic
Nou investigadors de
@hospitalclinic
/IDIBAPS i
@UniBarcelona
, al rànquing dels millors del món
2
12
48
1
5
33
Not retired at all. Mentoring includes making it easy to colleagues and fellows to be away and shine in talks and networks. Success in this action implies generosity but it secures the future of the group and this represents the best legacy.
@hospitalclinic
@idibaps
Intense week: Mona left. At the same time BCLC members or fellows presented in Portugal, Brazil & Spain, getting awards & always exposing our model. Nurses role shown in a symp. Great networking while Bruix and Mauro kept the pts clinical care in place
@hospitalclinic
@idibaps
0
5
18
0
0
32
This was a great event that should be regularly repeated. It is relevant to inform patients and get their feedback about our working plan and strategy to provide optimal care
@hospitalclinic
@idibaps
@CIBERehd
#LiverCancerAwarenessMonth
El
#CL
ÍNIC centra la jornada del mes del càncer de fetge en l’experiència del pacient.
🏥 La Unitat d’Oncologia Hepàtica ha celebrat una jornada de portes obertes per parlar sobre la importància d’implicar el pacient en la presa de decisions.
➕ info 👉
0
8
23
1
9
32
Because of the coincidence with the
#worldcancerday
and the
@EASLnews
#livercancersummit
Greg Gores and myself have granted free access to the liver cancer papers in
@SeminLiverDis
Click Great reviews to go through
#livertwitter
1
13
29
A great Sunday reading. Comments about what drives the investigators to present data in a given manner are even better that the teaching about the value of the p value. Training in statistics is key for investigators!!
doi: 10.1093/jncics/pkaa012
@idibaps
@ciberehd
#livertwitter
2
12
32
A brilliant researcher, a nice person and a committed physician. I am sure about her successful career. A pleasure to see her progress since we met at an EASL meeting she attended with her mentor Greg Gores. Here with
@PetraHirsova
during my Feb 2020 Mayo visit prior to COVID!!
#FeatureFriday
Dr.
@SumeraRizviMD
immigrated to the United States from Pakistan at age 10, graduated from GI and transplant hepatology fellowships
@MayoClinic
, and is now on staff. Her philosophy, "Do what you love and then find daily joy in what you end up doing."
#WomenInGI
8
5
86
2
3
29
My work highlight of 2022 is getting the
@ILCAnews
Nelson Fausto Award, but the most emotional impact of it was the unexpected attendance of the
@BCLC_group
members that appear in the picture. I was really touched by their presence and their happiness to be there!
0
5
31
It is great to see the career progression of
@sapisochin
!! From a shy fellow presenting at
@aasld
being affraid of my questions to a friend and leader in LT for liver cancer
@UHN
@UHNTransplant
👏👏👏🚴♂️
Liver cancer was a contraindication for LT 30 years ago. Now, it is a major indication for it and in need of research to secure optimal outcomes and the best use of organs
@hospitalclinic
@aeeh
@EASLnews
@AASLDtweets
@ilca
@ONT_esp
@GlobalLiver
@EuropeLiver
1
12
45
3
1
28
It is mandatory for leaders to prime fellows and coworkers, and not wait until retirement to allow their career growth. Have applied this at
@BCLC_group
and it is now great to share responsibilities and strategy to secure successful evolution
@hospitalclinic
@idibaps
@CIBERehd
@ma5RN
presented today the 1 year accomplishments since she took over the BCLC unit at
@hospitalclinic
@idibaps
as well as the future projects. All highly promising and thrilling.
@ILCAnews
@EASLnews
@aecc_es
@AEEHLiver
@CIBERehd
0
2
27
0
3
30
Insisteixo. Mèrit de tot el
@BCLC_group
. Rés funciona en solitari i sense esforç coordinat i generós
Un estudi constata que
@hospitalclinic
/ IDIBAPS és la institució més influent en recerca en Hepatologia del món
0
23
68
2
2
29
Merck Announces KEYTRUDA® (pembrolizumab) Met Primary Endpoint of Overall Survival (OS) in Patients with Advanced Hepatocellular Carcinoma Previously Treated with Sorafenib -
1
7
31
Thanks to L.Boix at
@BCLC_group
Writing grants is a painful process filled with success expectations!!
@idibaps
@hospitalclinic
@CIBERehd
0
1
30
I am happy to have left several sentences as a legacy. Still adding new ones. Pleasure to have you here with us
It was a pleasure to join today the
@BCLC_group
tribute to
@bruixj
in
#Barcelona
Great legacy, and inspiring to hear him saying “I had so much fun” and “I am my team”
#teamwork
#HCC
1
2
17
1
0
30
Happy and proud to join forces with several friends under Greg’s leadership. Liver cancer is a thrilling field and we look forward to great contributions.
AASLD would like to extend a special thank you to Dr. David Cohen for his excellent stewardship of HEPATOLOGY over the last 5 years. We now welcome Dr. Greg Gores, as he takes over as Editor in Chief January 2022 with a brand new look for AASLD’s flagship journal.
2
16
70
0
3
30
Control arms have to be adequate and offer the best evidence-based option. Otherwise, a positive trial may be non-informative and misleading
1
4
30
The primary end-point in
#livercancer
is survival and no other would be accepted. In end-stage cirrhosis, OS could be even worse, but other endpoints are supported even if OS is not different between arms. Not sure if it makes sense.
@EASLnews
@AASLDtweets
@ILCAnews
#livertwitter
0
4
28
Will do my best!!!
Coming soon in Avicenne hospital: Pr Jordi Bruix will talk about « Future Research in Hepatocellular Carcinoma: evidence versus marketing » Wednesday 13 october 2021 12h00-13h00 in salle de l hospitalité ! High level speaker for critical thinking in HCC !
@Avicenne_RMuret
@bruixj
2
5
34
2
4
29
More preparation for
#liver
cancer Summit by
@EASLnews
This session will deal with imaging and pathology diagnosis, future of t AI and the risks of overdiagnosis and overtreatment. Will be fun to debate with
@VChernyakMD
@tom_luedde
, M Ronot and S Thung!!
@AASLDtweets
@ILCAnews
1
8
29
Interaction with young investigatirs and bringing them into the issues around trial design and analysis is always fun and rewarding.
0
0
6
0
2
27
It was a pleasure to get this done with good friends such as Chan, Galle,
@LorenzaRimassa
and Sangro. Thanks to
@EASLnews
and its GB led by
@phil_newsome7
for the invitation to be part of the team.
The EASL position paper about systemic treatment for
#HCC
is online!!!
Our
@bruixj
at
@hospitalclinic
@idibaps
among the panel of experts.
@EASLnews
@AASLDtweets
@ILCAnews
@AEEHLiver
@asscatinforma
@myESMO
@aecc_es
0
13
44
0
3
27
Congratulations!! Nonstop progression to international leadership/recognition. Happy and proud to be part of the mentorship you received. Still remember the start of our debates/work for early cholangiocarcinoma. As said, a pleasure to see success of mentees.
Wonderful day
@_ILTS_
Extremely grateful and proud to receive the ILTS Clinical Science Investigator Award 🙌🙌. Thanks to all my peers, collaborators, partners and mentors imposible to do this without you
@GiveLifeUHN
@UHNTransplant
@UHN_Surgery
@UHN_Research
#transplantoncology
26
7
155
2
2
28
A successful generation renewal is key to allow a group to evolve and keep growing. Active work, mentorship and advice by prior leaders continues, but leadership and responsibility is transfered to prime evolution. Very proud of what has been accomplished
@hospitalclinic
@idibaps
We enjoyed the
#WCGIC2023
afternoon with the new
@BCLC_group
fellows
@martafortuny10
and
@belusabo
@CIBERehd
@hospitalclinic
@idibaps
1
5
39
0
3
27
Will not replace the BCLC logo but it is a nice icon for today. Will show later on the traditional “panellets” that we share tonight in Catalonia.
3
2
27
More reading for a Sunday while COVID confines us again. Informative censoring and PFS bias. Important concept to inspect trials. Very relevant when toxicity primes treatment discintinuation and withdrawal from follow-up.
PMID: 32273582 DOI: 10.1038/s41571-020-0368-0
@idibaps
0
4
27
Growth of mentees and now PIs in their area of interest is the best reward for a mentor
0
2
27
The 2022 BCLC model displayed by Peter Galle. Find it as Reig et al in
@JHepatology
2022. And avoid older versions and misleading modified approaches with wrong concepts. Original is better!!!
@hospitalclinic
Prof. Peter Galle at the
#ILC2022
Postgraduate Course on how personalised medicine may affect treatment strategies in
#HCC
#LiverTwitter
@EASLnews
@aelsharkawy75
@Apichatka
@jturnesv
0
3
16
0
5
25
No more questions, your honor!!
🔥hot off the press: Aetiology of liver disease and response to immune checkpoint inhibitors: an updated meta-analysis confirms benefit in those with non-viral liver disease
@JHepatology
😇we provide more data... still a controversial topic?
@EASLedu
1
33
97
1
6
27
In this editorial in
@HEP_Journal
with
@AngelesG_Criado
we explain the need to give patients full information about benefits and harms of screening for liver cancer. Very timely at the time of
#livercancermonth
@EuropeLiver
@EASLnews
@AASLDtweets
0
11
27
Marco Sanduzzi
@MarcoSanduzzi
and Maria Reig
@ma5RN
talking about hepatic angiosarcoma and hepatic hemangioendothelioma at the ERN meeting in Hamburg. Time to tackle rare hepatic tumors through international networks.
@hospitalclinic
@idibaps
@CIBERehd
@eurordis
0
7
27
0
7
26
COSMIC trial is out. Pity to be negative. Lots of learnings there: value of Response and PFS as surrogates for OS, role of etiology, stratification factors to use…….
1
13
26
Back from the funeral ceremony of Ricard Sola. He lived with passion his work as hepatologist as well as his intense life with multifaceted interests. A great loss for those of us who enjoyed his friendship.
@AEEHLiver
@IMIM_research
@hospitaldelmar
@SCDigestologia
0
4
25
A great team!!
Today is Nursing day and we will celebrate. Our team of nurses
@nllarch
@gemmaiserte
@mrtcampos
@NuriaGranel
&
@JuliaFarled
secures optimal care and research in
#livercancer
.
@gemmaiserte
is now at
@MayoClinicGIHep
to incorporate more expertise.
@hospitalclinic
@idibaps
0
6
42
1
3
26
Thanks! I did my best to control emotions. Award and talk by
@Zucmanrossi
were moving but the unexpected attendance of
@BCLC_group
members was a real shock that almost brought tears up.
@ILCAnews
@hospitalclinic
@bruixj
@Maria_Var_Cal
@ILCAnews
@BCLC_group
@hospitalclinic
@idibaps
Congrats Jordi. Well deserved ILCA award
@ILCAnews
. Beautiful words from
@Zucmanrossi
this morning. All of them true. Amazing
@BCLC
team, much needed impact into HCC. You didn’t but… I had one tear there. Congrats
0
0
3
0
5
25
So happy for this update that leaves behind all prior ones. Hope it will be a success because of wide recognition
🆕2022 update from the
@BCLC_group
Strategy for prognosis prediction & treatment recommendation of
#HCC
✅All dimensions of a patient’s profile are taken into account
✅Expert clinical decision-making process
Read the update here👉
#LiverTwitter
0
37
72
0
5
26
Flying towards Switzerland to talk about “Personalized medicine for HCC” at the Annual meeting in Interlaken. A joy to share knowledge/experience and meet years long friends
@docberza
&
@jaumebosch9
&
@HurstMajno
A great blend!!!
@hospitalclinic
@idibaps
0
1
26
If anybody though it would be easy to understand cancer development and progression please read
by Hanahan. One single dimension or path will never explain it all!!
@EASLnews
@ILCAnews
@AASLDtweets
@AEEHLiver
0
6
24
Sad to know the death of Roberto. An icon in portal hyp that I admired as a fellow with
@jaumebosch9
Their conversations and insight around hemodynamics were amazing. Attach a homage picture with him surrounded by friends at
@EASLnews
ILC2016 where he was awarded
@AASLDtweets
Dear
#livertwitter
#cirrhosis
#liver
community,
Sadly, Dr Roberto Groszmann died today
He was one of the legendary men bringing Hepatology to what it is today, a giant in the field of portal hypertension, a great mentor, a caring husband, father and friend
Will his memory remain!
38
45
210
1
1
25
Had fun writing this piece for
@JHepatology
so that concepts that are taken for granted are critically inspected. Will go online this Friday! Just on time for the
@EASLnews
#LiverCancerSummit
@ILCAnews
@aasld
@EuropeLiver
0
10
25
Systemic therapy for
#hcc
is getting complex. Expertise and clinical insight are mandatory for optimal outcomes. Evidence and robust data should prime over wishful thinking and marketing suggestions.
📢EASL’s new Position Paper provides guidance on systemic
#treatment
of
#livercancer
By
@bruixj
@StephenLChan1
Peter R. Galle
@LorenzaRimassa
& Bruno Sangro
➡️
Published in
@JHepatology
, it complements previous EASL Clinical Practice Guidelines
@EASLedu
1
24
40
0
4
25
Was fun to prepare this edutorial with
@AngelesG_Criado
. See DOI: 10.1097/HEP.0000000000000539 in
@HEP_Journal
Inform the patients about the pros and cons of entering a screening program and the potencial risk of associated harms and overdiagnosis is crucial to avoid anxiety and depression. Radiologist also have to become aware and get involved in this process.
@bruixj
0
4
22
0
2
25
At the beginning of my career I was told that liver cancer did not exist in the West and that I would not progress in academia. I did not fear and now the
@BCLC_group
is fully equipped and ready to blend research and practice for the benefit of those in need
A truly frightening glimpse into the current and future clinical world of primary liver cancer.
3
2
7
1
1
24
Thanks to you! The important aspect that glues all the work to be done is that we enjoy a happy/friendly human interaction based in trust. Success of one is shared by all. We have heterogeneous profiles with virtues-deffects, but the first ones prevail to deliver care& research.
Thank you to the
@BCLC_group
for an incredible conference which provided me knowledge of the BCLC philosophy and tips that I will bring to the UNC Multidisciplinary HCC clinic
I look forward to ongoing collaborations and future trips back
Thanks to
@AmCollegeGastro
travel grant
0
5
32
1
2
25